Pulsenmore (PLSM) Capital Leases (2025)
Pulsenmore (PLSM) reported Capital Leases of $4.2 million for Q4 2025.
Pulsenmore (PLSM) Capital Leases (2025) Analysis & Trends
Pulsenmore (PLSM) has 1 years of Capital Leases data on file, last reported at $4.2 million in Q4 2025.
- For the quarter ending Q4 2025, Capital Leases changed N/A year-over-year to $4.2 million; the trailing twelve-month figure through Dec 2025 stood at $4.2 million (changed N/A YoY), and the FY2025 full-year result was $4.2 million, changed N/A from the prior year.
- Capital Leases was little changed at $4.2 million in Q4 2025.
- In the past five years, Capital Leases ranged from a high of $4.2 million in Q4 2025 to a low of $4.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Pulsenmore | 22.61 Mn | 941,245.49 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.18 Mn |